Form 4 for ADCT ADC Therapeutics SA
Accepted 2024-12-09 00:00:00 ET · period of report 2024-12-06 · accession 0001628280-24-050541 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-09 | 2024-12-06 | ADCT | Carmona Jose | CFO | F - Tax | $3.13 | -48.1K | 301.9K | -14% | -$150.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-12-06 | F | D | 48,108 | $3.13 | 301,892 | D | — | — | (F1) Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted. |